ISSUE 1304
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Implantable cardioverter defibrillators (ICDs) are widely used in patients at risk for sudden cardiac death (SCD) because these devices have been highly successful in terminating life-threatening ventricular arrhythmias and in increasing survival.1
DEVICES — Current pulse generators are implanted subcutaneously in the pectoral area with single or dual pacing/defibrillator leads placed transvenously in the atria and ventricles.They are capable not only of defibrillating (>95% success rate) but also of dual chamber physiologic pacing, remote monitoring and discriminating (not always correctly) supraventricular from ventricular arrhythmias. The usual hospital bill for implanting a typical dual chamber device is about $75,000, and most must be replaced because of battery depletion after 5-7 years.
INDICATIONS — The goal of ICD therapy is to prevent premature arrhythmic death
... moreWould you like to read the rest of this article? Gain access below.
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App for iOS, Android, and Kindle Fire
- FREE online per issue CME/CE
Article code: 1304b
Electronic, downloadable article - $45